Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, Kerr T, Socías ME Use of cannabis as a harm reduction strategy among people who use drugs: a cohort study Cannabis Cannabinoid Res, 2023. PubMed
van Draanen J, Hamilton J, Morgan J, Maxwell S, Taylor T, Richardson L, Nolan S Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study Harm Reduct J, 2023. PubMed
Goodyear T, Oliffe JL, Parent N, Mniszak C, Jenkins E, Knight R Differentiating the role of alcohol in young men's use of substances with sex: a qualitative study Harm Reduct J, 2023. PubMed
Reddon H, Fairbairn N, Grant C, Milloy MJ Experiencing homelessness and progression through the HIV cascade of care among people who use drugs AIDS, 2023. PubMed
Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL Development of a neural network model to predict the presence of fentanyl in community drug samples PLoS One, 2023. PubMed
Morgan J, Neufeld SD, Holroyd H, Ruiz J, Taylor T, Nolan S, Glegg S Community-Engaged Research Ethics Training (CERET): developing accessible and relevant research ethics training for community-based participatory research with people with lived and living experience using illicit drugs and harm reduction workers Harm Reduct J, 2023. PubMed
Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Choi JC, Mok WY, Socías ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: secondary analysis of a pragmatic randomized trial Drug Alcohol Depend, 2023. PubMed
Mayer S, Boyd J, Fairbairn N, Chapman J, Brohman I, Jenkins E, McNeil R Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada Int J Drug Policy, 2023. PubMed
Brooks O, Ng JCY, Ickowicz S Outpatient rapid titration of slow release oral morphine for the treatment of opioid use disorder in a Canadian setting: a case series J Addict Med, 2023. PubMed
El-Akkad S, Nolan S, Hayashi K, Dong H, Milloy MJ, DeBeck K, Ti L Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada J Addict Dis, 2023. PubMed

